MetaCap

Guardian Pharmacy Services Inc. Class A (GRDN)

NYSE: GRDNConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD

46.94+0.27 (+0.58%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

GRDN stock chart

Technical analysis

Key statistics

All statistics
52-week range
26.34 – 50.85
Day range
46.13 – 47.48
Volume / Avg
526.70K / 547.39K
Beta
—

52-week range

$26.34$50.85

GRDN stock today

Shares of Guardian Pharmacy Services (GRDN) finished higher on Nov 20 at $46.94, a gain of 0.58% or $0.27 per share, versus the S&P 500's 3.70% decline. Shares are 7.7% below their 52-week high of $50.85, set on Nov 17, 2026 and 78.2% above the 52-week low of $26.34, near the top of the past year's range. GRDN is up 56.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 65.5%.

Guardian Pharmacy Services trades at 40.1x its trailing twelve-month earnings per share of $1.17. Its forward P/E of 31.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Guardian Pharmacy Services

Company profile

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs.

Industry
Retail-Drug Stores and Proprietary Stores
CEO
Mr. Fred P. Burke
Headquarters
Atlanta, GA
Employees
3,600
IPO year
2024

Financial highlights

Full financials

In fiscal 2025, Guardian Pharmacy Services generated $1.45 billion in revenue, up 17.9% from fiscal 2024. Net income was $49.2 million, for a net margin of 3.4% versus a median of -9.0% in the prior 1 years. Gross margin was 20.2% (up from 19.9%) and operating margin 5.0%.

Guardian Pharmacy Services annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024
Revenue$1.45B$1.23B
Growth+17.93%—
Net income$49.22M$-110.05M
EPS (diluted)——

Analyst forecast

Forecast

Consensus (7 analysts)

strong_buy

Avg. price target

$50.14+6.82%

  • Strong buy 1
  • Buy 6
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $47.00High $52.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$0.29 vs $0.28
Surprise
+3.57%

GRDN news

All GRDN news

Guardian Pharmacy Services peers

Consumer Staples sector
GRDN peer companies
CompanyPrice% ChgMarket capCompare
YI111 Inc. ADR2.36-5.98%$20.76Mvs GRDN
PETSPetMed Express Inc.0.8501-8.04%$18.90Mvs GRDN
RDGTRidgetech Inc.0.94-7.44%$3.41Mvs GRDN
CVSCVS Health Corporation80.84+1.00%$103.43Bvs GRDN

Indexes, lists and sector

Guardian Pharmacy Services stock FAQ

What is Guardian Pharmacy Services's stock price today?

GRDN last traded at $46.94 as of Nov 20, 4:00 PM EST, up 0.58% on the day. Prices are delayed at least 15 minutes.

What is GRDN's P/E ratio?

GRDN trades at a trailing P/E ratio of 40.12 and a forward P/E of 31.26.

Who is Guardian Pharmacy Services's CEO?

Mr. Fred P. Burke is the chief executive officer of Guardian Pharmacy Services Inc. Class A, which has about 3,600 employees.

What is the GRDN 52-week high?

The 52-week high for GRDN is $50.85 and the 52-week low is $26.34. The stock is currently 7.7% below its high.

Compare GRDN